Biotech

All Articles

Daiichi pays Merck $170M to create lung cancer cells T-cell engager pact

.Merck &amp Co. has promptly recouped several of the expenses of its Harpoon Rehabs acquistion, attr...

BioMarin halts preclinical genetics treatment for heart condition

.After BioMarin performed a spring season clean of its pipeline in April, the company has made a dec...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks deal

.Major Pharmas continue to be stuck to the concept of molecular adhesive degraders. The current prov...

Life science credit history agency reveals along with $600M

.A brand new global lifestyle science credit history company, referred to Symbiotic Funds, has actua...

BMS channels TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another major wager coming from the Caforio time, ending a b...

Nuvation standstills wager prevention after considering stage 1 data

.After having a look at period 1 data, Nuvation Bio has determined to stop service its one-time top ...

' Clinical intuition' led FDA experts to back Zevra's uncommon condition med

.Zevra Rehabs' rare illness medicine seems to become on the road to approval this fall after gaining...

Pfizer takes $230M hit after axing neglected DMD gene therapy

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) gene treatment failing has actually gone a $230 ...

AC Immune sees 'landmark' possible in Alzheimer's drug data

.After much more than 20 years of focus on neurodegenerative ailments, Swiss biotech hvac Immune sys...

GSK loses ph. 2 HPV vaccine over lack of best-in-class possible

.GSK has junked a phase 2 human papillomavirus (HPV) vaccination coming from its pipeline after deci...